Yamamoto K, Nakano Y, Tokumasu K, Honda H, Hasegawa K, Sato A, Ogawa H, Obika M, Hanayama Y, Otsuka F. Relationship between patients' characteristics and efficacy of calcimimetics for primary hyperparathyroidism in the elderly.
Clin Case Rep 2022;
10:e05713. [PMID:
35425612 PMCID:
PMC8991766 DOI:
10.1002/ccr3.5713]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Revised: 03/18/2022] [Accepted: 03/28/2022] [Indexed: 11/25/2022] Open
Abstract
Calcimimetic treatment has been reported to be effective for primary hyperparathyroidism (PHPT). Nine elderly PHPT patients who had been treated with calcimimetics were retrospectively analyzed. It was found that calcimimetics can reduce elevated serum calcium levels in elderly PHPT patients with low femoral DEXA %YAM and low urinary cAMP levels.
Collapse